October 3rd 2024
A single dose of the mRNA-1273.222 vaccine demonstrated strong immune responses against various omicron subvariants and showed a favorable safety profile compared to existing vaccines.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
"I want that!" TV advertising has a bad influence on young eating habits
January 13th 2006Every day, children are served up a barrage of television commercials telling them what to eat. According to J. Michael McGinnis, senior scholar at the Institute of Medicine (IOM), that's a problem: "Current food and beverage marketing practices put kids' long-term health at risk." McGinnis's findings appear in a report, Food Marketing to Children and Youth: Threat or Opportunity?, issued recently by the IOM's committee on food marketing and the diets of children and youth.
Anti-influenza drug's age indication expanded—downward—by FDA
January 13th 2006The US Food and Drug Administration in December approved the use of Tamiflu (oseltamivir phosphate) for preventing seasonal influenza in children 1 to 12 years old. Tamiflu's labeled use had previously been for prevention and treatment of flu in children 13 years and older, as well as in adults.
Update on the 2005-2006 Influenza Season
October 4th 2005"There is some drama associated with influenza every year," said George Kent, MD, associate director of the Center for Education in Family and Community Medicine at the Stanford University School of Medicine. "In 2004, it was the surprise vaccine shortage and the surge in demand, followed by a very ordinary year in terms of disease. This year, we appear to have plenty of vaccine, except for avian influenza, for which we have no vaccine at all."
Cold Injuries: A Guide to Preventing--and Treating--Hypothermia and Frostbite
October 1st 2005ABSTRACT: Hypothermia is not limited to the northern states: people also die of hypothermia in other areas with milder climates. Infants, young adolescent boys, and inadequately dressed teens who abuse alcohol or illicit drugs are at highest risk for death secondary to hypothermia. The mildly hypothermic patient may appear fatigued and display persistent shivering, ataxia, clumsiness, confusion, tachypnea, and tachycardia. The child with moderate hypothermia will not be shivering; declining mental status may cause the freezing patient to remove clothing. An irregular heartbeat is likely at this stage. Severe hypothermia is marked by apnea, stupor, and coma. In a frostbitten patient, rapid rewarming of the affected area in warm water for 15 to 30 minutes is the first step. Potent analgesia is often necessary. After thawing, the frostbitten part is kept dry, warm, and loosely covered. With an adequate dose of common sense, the vast majority of deaths from cold injury can be prevented.
PEDIATRICS UPDATE: Infectious Risk for Children in the Wake of Katrina
October 1st 2005In the aftermath of Hurricane Katrina's devastation in the Gulf Coast region, it is important for physicians in the United States to consider the infectious disease risks for children who have been displaced or who are still living in affected areas. These risks include infections acquired through ingestion of waterborne organisms; wound infections; lack of immunization continuity; and overcrowding, which increases the risk of respiratory or GI infections. In addition, problems will arise from disruption of therapy for select populations of children, such as those who are HIV-infected; those receiving immunosuppressive treatment; and those in need of continuous antibiotic prophylaxis, such as those who have sickle cell disease.
Patient education resources on flu available on the Web for in-practice use
September 1st 2005"Kids Need Flu Vaccine, Too!," a toolkit developed by the National Foundation for Infectious Diseases, now includes new material—available online—to help educate parents about influenza and the importance of annual flu vaccinations for infants and children.
Pneumonia: Update on Causes--and Treatment Options
September 1st 2005Pneumonia is one of the most common conditions encountered by primary care providers. Certain organisms cause pneumonia in particular age groups. For example, group B streptococci, Gram-negative bacilli Escherichia coli in particular) and, rarely, Listeria monocytogenes cause pneumonia in neonates. In infants younger than 3 months, group B streptococci and organisms encountered by older children occasionally cause pneumonia, as does Chlamydia trachomatis. Older infants and preschoolers are at risk for infection with Streptococcus pneumoniae and Haemophilus influenzae. In children older than 5 years, S pneumoniae and Mycoplasma pneumoniae are the key pathogens. Let the patient's age, history, clinical presentation, and radiographic findings guide your choice of therapy. Even though most patients with uncomplicated pneumonia can be treated as outpatients, close follow-up is important. Hospitalize patients younger than 6 months and those with complications.
Childhood immunization rates are on the rise
August 5th 2005The Centers for Disease Control and Prevention (CDC) announced that approximately 81% of the nation's toddlers are receiving all the vaccinations in the recommended series."These results are terrific news," said Dr. Julie Gerberding, director of the CDC. "They illustrate the tremendous progress we've made in preventing what were once common childhood diseases. Most importantly, these results show that parents have high levels of confidence in our vaccination recommendations. It's encouraging to see that parents recognize the importance of protecting their children against diseases that while relatively uncommon, can cause serious harm."
Fighting a rising tide of MRSA infection in the young
July 1st 2005The incidence of community-based methicillin-resistant Staphylococcus aureus (MRSA) infection in healthy children is increasing. This review discusses possible reasons for that rise, reviews antibiotic susceptibility patterns, and presents management guidelines.
Pediatrics Update: Methicillin-Resistant Staphylococcus aureus: How Best to Treat Now?
June 1st 2005Over the past 5 years, methicillin-resistant Staphylococcus aureus (MRSA) isolates have become widespread throughout the United States as well as the world.1 In some regions, including our own Gulf Coast, MRSA accounts for the majority of S aureus isolates recovered from patients with community-acquired infections.
Taking the long view of new goals for immunization
April 1st 2005With the recent licensing of conjugated, quadrivalent meningococcal vaccine (MCV4) and likely approval of other "childhood" vaccines to prevent disease during adolescence and adulthood, the national immunization program ventures onto new ground.